Sung Jun Ma, MD
Academic Title: Assistant Professor in the College of Medicine
About Me
More info forI am a radiation oncologist who specializes in treating thoracic cancers and head and neck cancers. My goal is always to provide the type of evidence-based, compassionate care that I would want my own loved ones to receive, and each of my patients can rely on me as a support system through their cancer journeys. It’s a privilege to do this work alongside such exceptional colleagues here at the OSUCCC – James, where everyone is committed to offering the most optimal and caring treatment possible. As a member of the Cancer Control Program at The James, my research interests are focused on machine learning in oncology and personalized medicine. I have co-authored over 70 peer-reviewed manuscripts and book chapters. I have had clinical trials funded by groups including the Roswell Park Comprehensive Cancer Center and the National Comprehensive Cancer Network/AstraZeneca. I am a member of the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), and the Korean American Society for Radiation Oncology (KASTRO).
Clinical Expertise
More info for- Skin Cancers
- Lung Cancers
- Head and Neck Cancer
Where I See Patients
More info forThe Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
460 W. 10th Ave. Columbus, Ohio 43210 800-293-5066 Location InformationEducation & Training
More info forInternship - Internal Medicine
- North Shore University Hospital-Manhasset
300 Community Dr Ofc Of, Manhasset, NY
Residency - Radiation Oncology
- Roswell Park Comprehensive Cancer Center
Elm And Carlton St, Buffalo, NY
Graduate
- State University of New York at Buffalo
1040 Kimball Tower, Buffalo, NY
- North Shore University Hospital-Manhasset
Academic Office & Contact Information
More info forAcademic Office:
James Cancer Hospital
460 W 10th Ave
Columbus, Ohio 43210-1240Email:
ma.2593@osu.eduPublications
More info forApril 13, 2024Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer.
Gill J, Yendamuri K, Chatterjee U, Yao S, Oladeru OT, Singh AK, Ma SJ
BMC Cancer
March 19, 2024Immunoprofiles and Oncologic Outcomes of 15 Patients with Androgen Receptor-Positive Salivary Duct Carcinoma.
Gogineni E, Sells BE, Dibs K, Jhawar SR, Haring CT, Limbach AL, Konieczkowski DJ, Ma SJ, Zhu S, Baliga S, Mitchell DL, Grecula JC, Bonomi M, Bhateja P, Old MO, Seim NB, Kang SY, Rocco JW, Chakravarti A, Blakaj DM, Gamez ME
Cancers (Basel)
March 5, 2024Palliative Quad Shot Radiation Therapy with or without Concurrent Immune Checkpoint Inhibition for Head and Neck Cancer.
Upadhyay R, Gogineni E, Tocaj G, Ma SJ, Bonomi M, Bhateja P, Konieczkowski DJ, Baliga S, Mitchell DL, Jhawar SR, Zhu S, Grecula JC, Dibs K, Gamez ME, Blakaj DM
Cancers (Basel)
December 1, 2023Outcomes of definitive local therapy with intensity-modulated radiation therapy in elderly patients ≥70 years with HPV-associated oropharyngeal cancer.
Baliga S, Yildiz V, Barve R, Farag A, Bhateja P, Gogineni E, Mitchell D, Konieczkowski D, Grecula J, Ma SJ, Zhu S, Liu X, Bonomi M, Blakaj DM
J Med Virol
October 2, 2023Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer.
Iovoli AJ, Turecki L, Qiu ML, Khan M, Smith K, Yu H, Ma SJ, Farrugia MK, Singh AK
JAMA Netw Open
Consulting and Related Relationships
More info forAt The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 09/30/2024, Dr. Ma has reported no relationships with companies or entities.